3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Conditions
Triple Negative Breast Neoplasms
14
Breast Neoplasms
8
Carcinoma, Non-Small-Cell Lung
6
Urinary Bladder Neoplasms
4
Endometrial Neoplasms
3
Carcinoma, Transitional Cell
3
Neoplasm Metastasis
2
Lung Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Uterine Cervical Neoplasms
1
Triple Negative Locally Advanced Non-resectable Breast Cancer
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms, Castration-Resistant
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Metastatic Urothelial Cancer
1
Metastatic Solid Tumors
1
Locally Advanced or Metastatic Unresectable Urothelial Cancer
1
Liver Failure
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Esophageal Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Advanced Solid Tumors
1
Interventions
pembrolizumab
133
Gemcitabine
101
Paclitaxel
100
Carboplatin
84
Nivolumab
66
Docetaxel
62
Bevacizumab
62
Cisplatin
57
Pemetrexed
50
Fluorouracil
49
Cyclophosphamide
41
Cetuximab
41
trametinib
38
venetoclax
37
Leucovorin
37
Irinotecan
37
Sorafenib
35
Capecitabine
35
Ipilimumab
33
Dexamethasone
32
atezolizumab
31
Erlotinib Hydrochloride
28
130-nm albumin-bound paclitaxel
28
Drug Therapy
27
Epoetin Alfa
26
Doxorubicin
25
Oxaliplatin
24
Albumin-Bound Paclitaxel
24
Prednisone
23
Rituximab
22
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Neoplasms
×
sacituzumab govitecan
×
Clear all
NCT05097599
2025-01-08
StrataPATH
Strata Oncology
Phase 2
Terminated
11 enrolled